Milada Šírová

1.4k total citations
45 papers, 1.2k citations indexed

About

Milada Šírová is a scholar working on Biomaterials, Molecular Biology and Biomedical Engineering. According to data from OpenAlex, Milada Šírová has authored 45 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Biomaterials, 15 papers in Molecular Biology and 15 papers in Biomedical Engineering. Recurrent topics in Milada Šírová's work include Nanoparticle-Based Drug Delivery (26 papers), Nanoplatforms for cancer theranostics (11 papers) and RNA Interference and Gene Delivery (8 papers). Milada Šírová is often cited by papers focused on Nanoparticle-Based Drug Delivery (26 papers), Nanoplatforms for cancer theranostics (11 papers) and RNA Interference and Gene Delivery (8 papers). Milada Šírová collaborates with scholars based in Czechia, Belarus and United States. Milada Šírová's co-authors include Blanka Řı́hová, Tomáš Etrych, Karel Ulbrich, Petr Chytil, Tomáš Mrkvan, J. Strohalm, Vladimír Šubr, Čestmı́r Koňák, Marek Kovář and P Roßmann and has published in prestigious journals such as Biomaterials, Cancer Research and Journal of Controlled Release.

In The Last Decade

Milada Šírová

44 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Milada Šírová Czechia 21 808 495 396 273 251 45 1.2k
Abby M. Gonik United States 5 766 0.9× 511 1.0× 489 1.2× 137 0.5× 157 0.6× 6 1.2k
Nicholas L. Fletcher Australia 24 685 0.8× 444 0.9× 546 1.4× 376 1.4× 184 0.7× 79 1.5k
Sharon M. Sagnella Australia 27 786 1.0× 470 0.9× 774 2.0× 320 1.2× 126 0.5× 45 1.8k
Jesse B. Wolinsky United States 8 747 0.9× 564 1.1× 425 1.1× 188 0.7× 334 1.3× 8 1.4k
Xinghai Li United States 23 775 1.0× 432 0.9× 629 1.6× 177 0.6× 89 0.4× 36 1.5k
Xianghui Xu China 24 747 0.9× 745 1.5× 821 2.1× 202 0.7× 299 1.2× 62 1.7k
Robert Pola Czechia 19 691 0.9× 647 1.3× 529 1.3× 183 0.7× 96 0.4× 58 1.4k
Libor Kostka Czechia 18 381 0.5× 315 0.6× 382 1.0× 188 0.7× 96 0.4× 47 925
Nate Larson United States 9 523 0.6× 391 0.8× 320 0.8× 157 0.6× 126 0.5× 10 878
Zachary H. Houston Australia 21 436 0.5× 314 0.6× 363 0.9× 302 1.1× 127 0.5× 45 1.1k

Countries citing papers authored by Milada Šírová

Since Specialization
Citations

This map shows the geographic impact of Milada Šírová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Milada Šírová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Milada Šírová more than expected).

Fields of papers citing papers by Milada Šírová

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Milada Šírová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Milada Šírová. The network helps show where Milada Šírová may publish in the future.

Co-authorship network of co-authors of Milada Šírová

This figure shows the co-authorship network connecting the top 25 collaborators of Milada Šírová. A scholar is included among the top collaborators of Milada Šírová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Milada Šírová. Milada Šírová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Šírová, Milada, et al.. (2025). Temporal optimization of CD25-biased IL-2 agonists and immune checkpoint blockade leads to synergistic anticancer activity despite robust regulatory T cell expansion. Journal for ImmunoTherapy of Cancer. 13(8). e010465–e010465. 1 indexed citations
2.
Kostka, Libor, Ladislav Sivák, Vladimír Šubr, et al.. (2022). Simultaneous Delivery of Doxorubicin and Protease Inhibitor Derivative to Solid Tumors via Star-Shaped Polymer Nanomedicines Overcomes P-gp- and STAT3-Mediated Chemoresistance. Biomacromolecules. 23(6). 2522–2535. 4 indexed citations
3.
Tomala, Jakub, Milada Šírová, Guy de Martynoff, et al.. (2022). SOT101 induces NK cell cytotoxicity and potentiates antibody-dependent cell cytotoxicity and anti-tumor activity. Frontiers in Immunology. 13. 989895–989895. 8 indexed citations
4.
Kostka, Libor, Eva Randárová, Carolina A. Ferreira, et al.. (2022). Evaluation of linear versus star-like polymer anti-cancer nanomedicines in mouse models. Journal of Controlled Release. 353. 549–562. 6 indexed citations
5.
6.
Kostka, Libor, Vladimír Šubr, Carolina A. Ferreira, et al.. (2019). HPMA-based star polymer biomaterials with tuneable structure and biodegradability tailored for advanced drug delivery to solid tumours. Biomaterials. 235. 119728–119728. 39 indexed citations
7.
Šírová, Milada, et al.. (2016). HPMA Copolymer-Based Polymer Conjugates for the Delivery and Controlled Release of Retinoids. Physiological Research. 65(Suppl 2). S233–S241. 9 indexed citations
8.
Šírová, Milada, J. Strohalm, Petr Chytil, et al.. (2016). The structure of polymer carriers controls the efficacy of the experimental combination treatment of tumors with HPMA copolymer conjugates carrying doxorubicin and docetaxel. Journal of Controlled Release. 246. 1–11. 24 indexed citations
9.
Kostka, Libor, Ladislav Sivák, Lucie Cuchalová, et al.. (2016). Tumor-targeted micelle-forming block copolymers for overcoming of multidrug resistance. Journal of Controlled Release. 245. 41–51. 45 indexed citations
10.
Šírová, Milada, P Roßmann, Robert Pola, et al.. (2015). The structure-dependent toxicity, pharmacokinetics and anti-tumour activity of HPMA copolymer conjugates in the treatment of solid tumours and leukaemia. Journal of Controlled Release. 223. 1–10. 35 indexed citations
11.
Řı́hová, Blanka, Tomáš Etrych, Milada Šírová, et al.. (2011). Synergistic effect of EMF–BEMER-type pulsed weak electromagnetic field and HPMA-bound doxorubicin on mouse EL4 T-cell lymphoma. Journal of drug targeting. 19(10). 890–899. 9 indexed citations
12.
Julien, Sylvie, Tobias Peters, Focke Ziemssen, et al.. (2011). Implantation of ultrathin, biofunctionalized polyimide membranes into the subretinal space of rats. Biomaterials. 32(16). 3890–3898. 30 indexed citations
13.
14.
Řı́hová, Blanka, Tomáš Etrych, Milada Šírová, et al.. (2010). Synergistic Action of Doxorubicin Bound to the Polymeric Carrier Based on N-(2-Hydroxypropyl)methacrylamide Copolymers through an Amide or Hydrazone Bond. Molecular Pharmaceutics. 7(4). 1027–1040. 27 indexed citations
15.
Chytil, Petr, Tomáš Etrych, Čestmı́r Koňák, et al.. (2006). Properties of HPMA copolymer–doxorubicin conjugates with pH-controlled activation: Effect of polymer chain modification. Journal of Controlled Release. 115(1). 26–36. 78 indexed citations
16.
Šírová, Milada, J. Strohalm, Vladimír Šubr, et al.. (2006). Treatment with HPMA copolymer-based doxorubicin conjugate containing human immunoglobulin induces long-lasting systemic anti-tumour immunity in mice. Cancer Immunology Immunotherapy. 56(1). 35–47. 54 indexed citations
17.
Kovářová, Hana, Danuta Radzioch, Marián Hajdúch, et al.. (1998). Natural resistance to intracellular parasites: A study by two‐dimensional gel electrophoresis coupled with multivariate analysis. Electrophoresis. 19(8-9). 1325–1331. 15 indexed citations
18.
Šírová, Milada, Ondřej Hovorka, I. Říha, et al.. (1997). The in vivo antibody response against exogenous antigens is not influenced by the mouse Bcg (Nramp1) gene. Immunology. 90(4). 626–631. 2 indexed citations
19.
Šírová, Milada, I. Říha, & Blanka Řı́hová. (1996). Limited T Helper Cell Activity in C57BL/10 (B10) Mice with Inherited Low IgG Responsiveness. Scandinavian Journal of Immunology. 44(5). 453–460. 6 indexed citations
20.
Šírová, Milada, Blanka Řı́hová, I. Říha, & Carola Leipner. (1993). IL-2 and IL-3 production in high and low IgG-responding strains of mice. Immunology Letters. 37(1). 91–96. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Abby M. Gonik Breakdown of academic impact, for papers by Nicholas L. Fletcher Breakdown of academic impact, for papers by Sharon M. Sagnella Breakdown of academic impact, for papers by Jesse B. Wolinsky Breakdown of academic impact, for papers by Xinghai Li Breakdown of academic impact, for papers by Xianghui Xu Breakdown of academic impact, for papers by Robert Pola Breakdown of academic impact, for papers by Libor Kostka Breakdown of academic impact, for papers by Nate Larson Breakdown of academic impact, for papers by Zachary H. Houston
Rankless by CCL
2026